Kevin Pollack
2012
In 2012, Kevin Pollack earned a total compensation of $40K as CFO at OPIANT PHARMACEUTICALS.
Compensation breakdown
| Option Awards | $40,000 |
|---|---|
| Total | $40,000 |
Pollack received $40K in option awards, accounting for 100% of the total pay in 2012.
Rankings
In 2012, Kevin Pollack's compensation ranked 11,405th out of 11,487 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,405 out of 11,487 | 1st |
Division Mining | 564 out of 576 | 2nd |
Major group Metal Mining | 72 out of 74 | 3rd |
Source: SEC filing on September 11, 2014.
Pollack's colleagues
We found two more compensation records of executives who worked with Kevin Pollack at OPIANT PHARMACEUTICALS in 2012.